Donation of Convalescent Plasma

Convalescent Plasma for the Treatment of COVID-19 and Donation of Convalescent Plasma
Use of convalescent plasma to treat COVID-19 patients

People who have recovered from COVID-19 have antibodies – proteins the body uses to fight off infections – to the disease in their blood. Doctors call this convalescent plasma. COVID-19 convalescent plasma has not yet been approved for use by the Food and Drug Administration (FDA) and is regulated as an investigational product.  A study by Mayo Clinic researchers of 20,000 hospitalized patients transfused with investigational convalescent plasma published in June 2020 concluded there was “robust evidence” it was safe and supported earlier administration of plasma within the clinical course of COVID-19 was “more likely to reduce mortality.” The following pathways are available for the use of COVID-19 convalescent plasma:

Guidance on the Use of Masks by the General Public

SARS-CoV-2 is a novel coronavirus that has emerged and caused coronavirus disease (abbreviated as COVID-19). Public health experts continue to learn about COVID-19, but based on current data and similar coronaviruses, the virus is believed to be spread between close contacts via respiratory droplets or contact with contaminated surfaces. While staying home, social distancing, and strict hand hygiene are still preferred methods for preventing further spread of COVID-19, face masks are one more tool that may be used by the general public and essential workers to protect each other from respiratory droplets produced when we cough, sneeze, or talk.

Guidance for Congregate Living Facilities

Interim Recommendations to Reduce Transmission of SARS-CoV-2 in Congregate Living Facilities: Universal Masking and Enhanced Environmental Disinfection

Purpose

This guidance provides universal masking and environmental disinfection recommendations for congregate living facilities in dealing with SARS-CoV-2, the virus that causes COVID-19.

Homeless Shelters Guidance

This Illinois Department of Public Health (IDPH) COVID-19 guidance provides recommendations for homeless shelters and is intended to support response planning by homeless service providers, including overnight emergency shelters, day shelters, and meal service providers. The Before, During, and After sections of this guidance offer suggested strategies to help homeless service providers plan, prepare, and respond to the threat of COVID-19.

Business and Organization Guidance

The following interim guidance may help prevent workplace exposures to acute respiratory illnesses, including COVID-19, in non-health care settings. The guidance also provides planning considerations in the event of widespread, community outbreaks of COVID-19.

To prevent stigma and discrimination in the workplace, use only the guidance described below to determine risk of COVID-19. Do not make risk determinations based on race or country of origin and be sure to maintain confidentiality of people with confirmed COVID-19. There is much more to learn about the transmissibility, severity, and other features of COVID-19 and investigations are ongoing.

Pages

Subscribe to RSS - Community Settings